Home
>
National Drug Code (NDC)
>
REVATIO
REVATIO - 0069-0336-21 - (SILDENAFIL CITRATE)
Drug Information of REVATIO
| Product NDC: | 0069-0336 |
| Proprietary Name: | REVATIO |
| Non Proprietary Name: | SILDENAFIL CITRATE |
| Active Ingredient(s): | 10 mg/mL & nbsp; SILDENAFIL CITRATE |
| Administration Route(s): | ORAL |
| Dosage Form(s): | SUSPENSION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of REVATIO
| Product NDC: | 0069-0336 |
| Labeler Name: | Pfizer Laboratories Div Pfizer Inc |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA203109 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20120830 |
Package Information of REVATIO
| Package NDC: | 0069-0336-21 |
| Package Description: | 125 mL in 1 BOTTLE, GLASS (0069-0336-21) |
NDC Information of REVATIO
| NDC Code | 0069-0336-21 |
| Proprietary Name | REVATIO |
| Package Description | 125 mL in 1 BOTTLE, GLASS (0069-0336-21) |
| Product NDC | 0069-0336 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | SILDENAFIL CITRATE |
| Dosage Form Name | SUSPENSION |
| Route Name | ORAL |
| Start Marketing Date | 20120830 |
| Marketing Category Name | NDA |
| Labeler Name | Pfizer Laboratories Div Pfizer Inc |
| Substance Name | SILDENAFIL CITRATE |
| Strength Number | 10 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Phosphodiesterase 5 Inhibitor [EPC],Phosphodiesterase 5 Inhibitors [MoA] |
